Anzeige
Mehr »
Samstag, 26.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JPMY | ISIN: US64131A1051 | Ticker-Symbol: NRC
Tradegate
25.07.25 | 18:19
3,785 Euro
-1,17 % -0,045
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEURONETICS INC Chart 1 Jahr
5-Tage-Chart
NEURONETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,7503,89025.07.
3,8103,84525.07.

Aktuelle News zur NEURONETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.07.Neuronetics names Steven Pfanstiel chief financial officer2
15.07.Neuronetics Appoints Steven Pfanstiel As CFO; Reaffirms Q2, FY25 Guidance1
15.07.Neuronetics appoints Steven Pfanstiel as chief financial officer1
15.07.Neuronetics Appoints New Chief Financial Officer83Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession...
► Artikel lesen
15.07.Neuronetics, Inc. - 8-K, Current Report1
09.07.Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting2
20.06.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)95MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
10.06.Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program2
NEURONETICS Aktie jetzt für 0€ handeln
02.06.Neuronetics to join Russell 3000 and Russell 2000 indexes3
02.06.Neuronetics set to join Russell indexes in June1
02.06.Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes2
28.05.Neuronetics, Inc. - 8-K, Current Report1
14.05.Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month1
06.05.Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth2
06.05.Neuronetics, Inc. - 10-Q, Quarterly Report1
06.05.Neuronetics reports mixed Q1 results; initiates Q2 and reaffirms FY25 outlook1
06.05.Neuronetics Reports First Quarter 2025 Financial and Operating Results246MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company...
► Artikel lesen
06.05.Neuronetics, Inc. - 8-K, Current Report1
05.05.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)99MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
30.04.Why Neuronetics, Inc. (STIM) is Surging in 20251
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1